Physician Assistant · Durham, NC
NPI
1235487497
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
30 Duke Medicine Cir # 1a
Durham, NC, 27710
Phone (919) 684-3600
Groups this clinician bills Medicare through
Medicare paid, 2024
$84K
1,316 services
Medicare patients, 2024
972
Average age 76
Drug cost, 2024
$3.0M
2,359 prescriptions
Company payments, 2025
$210
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick B Cacchio was code 99214 (office e&m - established), 526 times for 449 patients. In total Patrick B Cacchio billed 1,316 services in 16 codes, and Medicare paid $84K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 526 | 449 | $65.99 | $35K |
| 99214 Office E&M - Established | Facility | 254 | 230 | $49.23 | $13K |
| 99213 Office E&M - Established | Office | 135 | 119 | $48.51 | $6,549 |
| 99205 Office E&M - New | Office | 87 | 87 | $129.20 | $11K |
| 99215 Office E&M - Established | Office | 69 | 65 | $98.95 | $6,827 |
| 99213 Office E&M - Established | Facility | 44 | 36 | $39.92 | $1,756 |
| 99205 Office E&M - New | Facility | 40 | 40 | $92.23 | $3,689 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 31 | $7.00 | $217 |
| 99451 E&M - Miscellaneous | Office | 28 | 28 | $22.23 | $622 |
| 99215 Office E&M - Established | Facility | 23 | 23 | $85.75 | $1,972 |
| 99204 Office E&M - New | Office | 22 | 22 | $79.97 | $1,759 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 20 | 20 | $5.17 | $103 |
By year: 2022 $92K for 1,232 services; 2023 $89K for 1,184 services; 2024 $84K for 1,316 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patrick B Cacchio prescribed most often to Medicare patients was Alendronate Sodium, with 640 prescriptions and refills. In total Patrick B Cacchio wrote 2,359 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alendronate Sodium Generic | 640 | 1,529 | 195 | $12K |
| Risedronate Sodium Generic | 320 | 691 | 97 | $20K |
| Risedronate Sodium Dr Risedronate Sodium | 302 | 657 | 98 | $82K |
| Levothyroxine Sodium Generic | 165 | 460 | 56 | $1,917 |
| Synthroid Levothyroxine Sodium | 134 | 344 | 34 | $12K |
| Tymlos Abaloparatide | 101 | 109 | 13 | $263K |
| Ibandronate Sodium Generic | 90 | 214 | 24 | $2,525 |
| Teriparatide Generic | 40 | 40 | Under 11 | $94K |
| Forteo Teriparatide | 40 | 40 | Under 11 | $139K |
| Testosterone Generic | 30 | 42 | Under 11 | $9,302 |
| Testosterone Cypionate Generic | 30 | 50 | Under 11 | $1,303 |
| Methimazole Generic | 26 | 46 | Under 11 | $335 |
| Calcitriol Generic | 26 | 65 | Under 11 | $800 |
| Crysvita Burosumab-Twza | 24 | 24 | Under 11 | $658K |
| Hydrocortisone Generic | 20 | 42 | Under 11 | $460 |
Brand drugs: 770 claims; generic drugs: 1,540 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick B Cacchio $210 ($210 in general payments such as food, travel and fees) from 1 company. The largest payer was Kyowa Kirin, Inc. with $210.
| Company | Payments | Amount |
|---|---|---|
| Kyowa Kirin, Inc. 4151.T | 1 | $210 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.